These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 37559243)
1. Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder. Su WJ; Hu T; Jiang CL Curr Neuropharmacol; 2024; 22(5):810-842. PubMed ID: 37559243 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo. Fourrier C; Sampson E; Mills NT; Baune BT Trials; 2018 Aug; 19(1):447. PubMed ID: 30126458 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Köhler-Forsberg O; N Lydholm C; Hjorthøj C; Nordentoft M; Mors O; Benros ME Acta Psychiatr Scand; 2019 May; 139(5):404-419. PubMed ID: 30834514 [TBL] [Abstract][Full Text] [Related]
5. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. Leblé N; Radon L; Rabot M; Godart N Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: A systematic review of randomized clinical trials. Allison DJ; Sharma B; Timmons BW Physiol Behav; 2019 Aug; 207():104-112. PubMed ID: 31078670 [TBL] [Abstract][Full Text] [Related]
7. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378 [TBL] [Abstract][Full Text] [Related]
8. Considerations when selecting an antidepressant: a narrative review for primary care providers treating adults with depression. Montano CB; Jackson WC; Vanacore D; Weisler R Postgrad Med; 2023 Jun; 135(5):449-465. PubMed ID: 36912037 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder. Plank JR; Glover SC; Moloney BD; Hoeh NR; Sundram F; Sumner RL; Muthukumaraswamy S; Lin JC Trials; 2022 Sep; 23(1):822. PubMed ID: 36175917 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. Kopschina Feltes P; Doorduin J; Klein HC; Juárez-Orozco LE; Dierckx RA; Moriguchi-Jeckel CM; de Vries EF J Psychopharmacol; 2017 Sep; 31(9):1149-1165. PubMed ID: 28653857 [TBL] [Abstract][Full Text] [Related]
11. Targeting inflammatory pathways for treatment of the major depressive disorder. Patil CR; Suryakant Gawli C; Bhatt S Drug Discov Today; 2023 Sep; 28(9):103697. PubMed ID: 37422168 [TBL] [Abstract][Full Text] [Related]
12. Targeting cytokines in reduction of depressive symptoms: A comprehensive review. Shariq AS; Brietzke E; Rosenblat JD; Barendra V; Pan Z; McIntyre RS Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():86-91. PubMed ID: 29309829 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trial. Suneson K; Ängeby F; Lindahl J; Söderberg G; Tjernberg J; Lindqvist D BMC Psychiatry; 2022 Dec; 22(1):801. PubMed ID: 36536364 [TBL] [Abstract][Full Text] [Related]
14. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Hannestad J; DellaGioia N; Bloch M Neuropsychopharmacology; 2011 Nov; 36(12):2452-9. PubMed ID: 21796103 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials. Bai S; Guo W; Feng Y; Deng H; Li G; Nie H; Guo G; Yu H; Ma Y; Wang J; Chen S; Jing J; Yang J; Tang Y; Tang Z J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):21-32. PubMed ID: 31658959 [TBL] [Abstract][Full Text] [Related]
16. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials. Maneeton N; Maneeton B; Srisurapanont M; Martin SD BMC Psychiatry; 2012 Sep; 12():160. PubMed ID: 23017200 [TBL] [Abstract][Full Text] [Related]
17. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials. Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001 [TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids for depression in adults. Appleton KM; Voyias PD; Sallis HM; Dawson S; Ness AR; Churchill R; Perry R Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004692. PubMed ID: 34817851 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. Berman RM; Fava M; Thase ME; Trivedi MH; Swanink R; McQuade RD; Carson WH; Adson D; Taylor L; Hazel J; Marcus RN CNS Spectr; 2009 Apr; 14(4):197-206. PubMed ID: 19407731 [TBL] [Abstract][Full Text] [Related]
20. Antidepressants for the treatment of depression in people with cancer. Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]